Keyphrases
Cysteine
16%
Cystine-glutamate Antiporter
100%
Cystine-glutamate Exchange
50%
Discrete Trials
16%
Dorsolateral Prefrontal Cortex (DLPFC)
16%
Extracellular Glutamate
16%
Extrasynaptic
16%
Glutamate
16%
Glutamate Receptors
16%
Glutamate Signaling
33%
Group II mGluRs
33%
LY341495
16%
Maze Task
16%
Metabotropic
16%
MGluR
16%
N-acetylcysteine
100%
Neural Disorders
16%
Non-vesicular Release
33%
Phencyclidine
100%
Postmortem Tissue
16%
Prefrontal Cortex
33%
Prodrug
16%
Protein Level
16%
Psychotomimetic Effects
100%
Release Mechanism
33%
Rodents
16%
Schizophrenia
16%
Schizophrenia Models
16%
Schizophrenic Patients
16%
Social Interaction
16%
Social Withdrawal
16%
Steady State
16%
Synaptic
16%
Synaptic Receptors
16%
Systemic Administration
16%
Working Memory
16%
Working Memory Deficits
16%
Neuroscience
4 Carboxyphenylglycine
9%
Acetylcysteine
54%
Antiporter
100%
Cysteine
9%
Cystine
100%
Dorsolateral Prefrontal Cortex
9%
Glutamate Receptor
9%
Glutamic Acid
100%
Phencyclidine
100%
Prefrontal Cortex
18%
Prodrug
9%
Psychotomimetic
100%
Receptor
9%
Social Interaction
9%
Working Memory
18%
Pharmacology, Toxicology and Pharmaceutical Science
2 Amino 2 (2 Carboxycyclopropyl) 3 (Xanthen 9 Yl)propionic Acid
9%
4 Carboxyphenylglycine
9%
Antiporter
100%
Cysteine
9%
Cystine
100%
Glutamate Receptor
9%
Glutamic Acid
100%
N-Acetylcysteine
54%
Phencyclidine
100%
Prodrug
9%
Psychotomimetic
100%
Receptor
9%
Systemic Administration
9%